evolutionarili
conserv
aaa
atpas
valosincontain
protein
vcp
previous
shown
provir
host
factor
sever
virus
differ
viral
famili
flavivirida
picornavirida
herpesvirida
vcp
shown
affect
traffick
sindbi
viru
receptor
function
compon
semliki
forest
viru
sfv
replicas
compart
howev
role
cellular
protein
evalu
replic
alphavirus
includ
chikungunya
viru
chikv
use
sirna
chemic
inhibitor
transrepl
assay
show
vcp
provir
factor
involv
replic
chikv
immunofluoresc
assay
confirm
vcp
coloc
nonstructur
replicas
protein
dsrna
foci
possibl
due
vcp
epitop
unavail
vcp
provir
role
also
observ
alphavirus
onyongnyong
viru
onnv
sfv
differ
human
cell
line
vcp
provir
role
sever
viral
famili
extend
replic
alphavirus
chikv
onnv
emphas
pivot
role
vcp
virushost
interact
biolog
valosincontain
protein
vcp
also
name
member
hexamer
aaa
atpas
famili
highli
conserv
across
domain
life
erzberg
berger
barthelm
sauer
molecular
function
vcp
atpdriven
protein
unfold
ye
et
al
van
den
boom
meyer
depend
differ
associ
cofactor
hanzelmann
schindelin
involv
mani
cellular
pathway
rang
endoplasm
reticulum
er
mitochondri
associ
protein
degrad
taylor
rutter
wolf
stolz
ubiquitin
proteasom
system
up
meyer
et
al
chromatin
structur
regul
torrecilla
et
al
dna
break
repair
torrecilla
et
al
dna
replic
activ
schweitzer
et
al
stall
ribosom
turnov
verma
et
al
endomembran
fusion
zhang
wang
full
capac
autophagi
lysosom
system
papadopoulo
meyer
lipid
droplet
turnov
olzmann
et
al
valosincontain
protein
report
proor
antivir
host
factor
sever
virus
picornavirus
arita
et
al
wu
et
al
wang
et
al
flavivirus
yi
et
al
phongphaew
et
al
yi
yuan
coronavirus
herpesviru
lin
et
al
phleboviru
brahm
et
al
even
insect
nucleopolyhedroviru
lyupina
et
al
case
picornavirus
singlestrand
rna
posit
ssrna
vcp
implic
provir
factor
replic
polioviru
sever
viral
protein
show
direct
interact
arita
et
al
wang
et
al
knockdown
vcp
enhanc
aichi
viru
arita
et
al
vcp
describ
import
host
factor
sever
flavivirus
ssrna
west
nile
viru
replic
phongphaew
et
al
well
compon
hepat
c
viru
hcv
shown
prevent
hcv
replicas
aggreg
yi
et
al
yi
yuan
specif
case
ssrna
alphavirus
famili
togavirida
vcp
shown
provir
factor
sindbi
viru
sinv
traffick
sinv
receptor
plasma
membran
rose
et
al
panda
et
al
howev
chikungunya
viru
chikv
alphavirus
bind
entri
independ
rose
et
al
addit
vcp
later
identifi
mass
spectrometri
replic
complexassoci
protein
semliki
forest
viru
sfv
infect
varjak
et
al
howev
role
aaa
atpas
investig
replic
alphavirus
studi
use
combin
knockdown
chemic
inhibitor
timeofaddit
assay
vcp
shown
import
provir
factor
necessari
replic
sever
isol
chikv
onyongnyong
viru
onnv
sfv
use
chikv
transrepl
system
vcp
verifi
import
factor
requir
rna
replic
viru
life
cycl
stabil
nonstructur
protein
nsp
also
show
vcp
coloc
sever
nsp
elucid
molecular
mechan
involv
vcp
provir
role
includ
viral
interact
protein
partner
crucial
develop
therapi
target
vcp
provir
function
potenti
effici
sever
viral
famili
order
assess
vcp
role
chikv
infect
transfect
mix
three
sirna
target
vcp
follow
infect
chikvexpress
gaussia
luciferas
gluc
insert
nonstructur
structur
code
region
indirect
marker
viral
replic
perform
reduct
vcp
protein
level
verifi
western
blot
assay
h
time
infect
h
postsirna
transfect
h
post
infect
time
supernat
collect
figur
knockdown
vcp
significantli
reduc
increas
viral
rna
supernant
hpi
figur
next
valid
gluc
luminesc
correl
viral
rna
viral
particl
amount
cell
supernat
supplementari
figur
confirm
gluc
luminesc
could
use
marker
viral
replic
use
gluc
confirm
vcp
knockdown
sever
impact
viral
replic
figur
order
valid
effect
due
vcpdepend
releas
secret
defect
gluc
viral
particl
experi
repeat
use
viru
express
nonsecret
zsgreen
report
instead
mark
infect
cell
context
vcp
knockdown
also
significantli
reduc
viral
infect
figur
e
taken
togeth
result
suggest
provir
role
vcp
chikv
infect
order
circumv
limit
assess
variou
step
viral
cycl
affect
vcp
knockdown
vcpspecif
chemic
inhibitor
timeofaddit
assay
explor
differ
chemic
inhibitor
assess
includ
dbeq
revers
inhibitor
vcp
fang
et
al
specif
alloster
vcp
inhibitor
magnaghi
et
al
oral
bioavail
activ
compound
deriv
scaffold
dbeq
anderson
et
al
notabl
shown
select
specif
inhibit
atpas
activ
domain
vcp
bind
nucleotid
bind
site
tang
et
al
vcp
inhibitor
show
dosedepend
effect
gluc
product
approxim
effect
concentr
rang
figur
toxic
differ
inhibitor
differ
concentr
verifi
use
cell
titer
glo
assay
show
cytotox
concentr
close
respect
dbeq
suggest
inhibitori
effect
viral
gluc
product
could
link
cytotox
effect
howev
signific
toxic
observ
figur
suggest
inhibitori
effect
viral
gluc
product
due
cytotox
interestingli
timeofaddit
chemic
inhibitor
rel
viral
infect
signific
impact
antichikv
figur
f
lowest
figur
taken
togeth
result
suggest
antivir
effect
vcp
inhibitor
post
bind
entri
step
valid
vcp
involv
chikv
bind
entri
bind
assay
perform
ice
c
h
presenc
dmso
control
wash
step
rna
extract
cell
chikv
rna
quantifi
rel
gapdh
rna
individu
sampl
bind
ice
differ
rel
amount
chikv
rna
observ
vcp
inhibit
treatment
compar
control
sampl
figur
intriguingli
higher
chikv
rna
level
dmso
controltr
sampl
observ
bind
perform
c
suggest
vcp
could
involv
earli
postentri
replic
step
togeth
bind
ice
lower
repres
imag
brightfield
auto
exposur
fitc
fix
exposur
channel
epifluoresc
microscop
hpi
data
present
mean
sd
minimum
three
independ
experi
two
panel
b
analyz
mannwhitney
nonparametr
twotail
test
p
p
figur
vcp
chemic
inhibit
affect
chikv
infect
thirti
thousand
hek
cell
per
well
plate
fibronectin
coat
treat
vcp
inhibitor
dbeq
dmso
control
time
indic
panel
rel
infect
pfu
gluctag
chikv
per
well
hpi
luminesc
quantifi
supernat
data
present
luminesc
compar
nontreat
infect
cell
yaxi
concentr
inhibitor
xaxi
viru
allow
bind
cell
h
ice
inocul
remov
virusfre
media
compound
appli
cell
move
back
c
b
viru
appli
cell
time
compound
remov
h
virusfre
media
compound
replac
cell
c
viru
appli
h
respect
inoculum
remov
compound
appli
e
cytotox
compound
assess
compound
celltiterglo
assay
without
infect
h
post
treatment
f
valu
panel
ae
calcul
use
nonlinear
regress
analysi
inhibitor
vs
normal
respons
variabl
slope
function
graphpad
prism
data
present
panel
ae
mean
sem
three
independ
experi
nd
determin
amount
chikv
rna
treat
group
indic
replic
occur
dmso
control
treat
group
confirm
observ
cell
treat
entri
inhibitor
obatoclax
olx
varghes
et
al
olx
togeth
hpi
assess
rel
amount
viral
rna
h
posttreat
h
post
viru
addit
figur
vcp
inhibit
result
reduc
viral
rna
level
compar
entri
inhibit
alon
olx
h
posttreat
figur
taken
togeth
result
show
vcp
inhibit
affect
post
bind
entri
replic
step
confirm
inhibit
vcp
impact
viral
rna
replic
chikv
transrepl
system
establish
figur
utt
et
al
abraham
et
al
system
nsp
encod
separ
plasmid
express
constitut
frontier
microbiolog
wwwfrontiersinorg
figur
vcp
involv
chikv
bind
entri
b
two
hundr
thousand
hek
cell
per
well
infect
moi
h
dmem
media
media
ice
c
respect
cell
wash
twice
pb
collect
rna
extract
c
two
hundr
thousand
cell
per
well
infect
moi
h
dmem
media
media
olx
h
inoculum
remov
cell
wash
twice
incub
h
media
media
olx
media
olx
cell
wash
twice
collect
rna
extract
rel
chikv
rna
fold
chang
compar
control
use
c
method
symbol
repres
independ
well
data
present
three
independ
experi
panel
c
two
independ
experi
panel
b
repres
mean
sd
analyz
mannwhitney
nonparametr
twotail
test
panel
p
use
cmv
promot
utt
et
al
plasmid
figur
sinc
use
viral
rna
templat
gener
cellular
rna
polymeras
ii
could
produc
high
background
signal
utt
et
al
abraham
et
al
bartholomeeusen
et
al
replicas
chikv
capabl
use
noncap
rna
templat
utt
et
al
human
rna
polymeras
promot
use
gener
noncap
viral
rna
templat
plasmid
figur
utt
et
al
templat
code
firefli
luciferas
fluc
instead
nonstructur
openread
frame
orf
code
tdtomato
instead
structur
orf
plasmid
figur
report
would
translat
templat
rna
replic
viral
replicas
minim
express
either
report
absenc
templat
rna
replic
thu
tdtomato
protein
would
express
detect
rna
replic
occur
allow
us
assess
effect
vcp
inhibitor
viral
replic
use
system
first
verifi
vcp
inhibit
effect
transcript
rna
polymeras
quantifi
fluc
rna
level
rel
gapdh
absenc
replicas
protein
plasmid
alon
figur
surprisingli
increas
templat
rna
level
found
sampl
suggest
vcp
inhibit
figur
vcp
essenti
chikv
replicas
activ
hek
cell
cotransfect
plasmid
alon
panel
b
plasmid
ratio
panel
ce
h
post
transfect
media
refresh
dmso
control
h
post
media
refresh
cell
collect
separ
rna
extract
whole
cell
lysat
flow
cytometri
analysi
schemat
represent
chikv
transrepl
plasmid
system
use
b
rel
fluc
rna
fold
chang
compar
control
use
c
method
c
repres
western
blot
whole
cell
lysat
probe
gapdh
chikv
protein
respect
rel
quantif
protein
amount
versu
gapdh
experiment
replic
e
mean
fluoresc
intens
mfi
tdtomato
assess
flow
cytometri
tdtomato
posit
cell
data
present
three
independ
experi
two
panel
b
analyz
mannwhitney
nonparametr
twotail
test
p
could
increas
rna
polymeras
transcript
orand
increas
stabil
noncap
rna
transcript
next
verifi
vcp
inhibit
affect
express
nsp
cmv
plasmid
assess
protein
level
western
blot
figur
altogeth
result
show
neg
effect
product
chikv
replicas
protein
templat
rna
howev
replicas
templat
coexpress
vcp
chemic
inhibit
drastic
decreas
amount
tdtomato
mean
fluoresc
intens
mfi
detect
per
transfect
cell
figur
despit
increas
fluc
rna
templat
avail
result
confirm
vcp
provir
factor
essenti
chikv
replic
post
entri
step
next
assess
vcp
coloc
specif
particular
nsp
use
confoc
microscopi
observ
vcp
partial
coloc
figur
figur
figur
virusinfect
cell
unfortun
assay
well
dsrna
coloc
vcp
could
assess
due
lack
suitabl
speci
compat
antibodi
respect
pearson
correl
coeffici
acquir
imag
indic
vcp
coloc
figur
result
suggest
vcp
could
like
interact
multipl
viral
nsp
associ
nsp
replicas
complex
order
perform
provir
function
assess
vcp
could
local
dsrna
replic
complex
therefor
assess
perform
polyclon
rabbit
antivcp
antibodi
immunofluoresc
assay
would
allow
coloc
mous
antibodi
recogn
dsrna
use
combinait
antibodi
observ
coloc
vcp
dsrna
foci
figur
interestingli
antibodi
vcp
present
differ
local
pattern
mous
monoclon
antibodi
use
previous
infect
noninfect
condit
figur
sinc
rabbit
antibodi
direct
ntermin
gave
punctuat
local
differ
pattern
observ
previous
near
cytosol
membran
mous
monoclon
antibodi
vcp
ctermin
figur
assess
coloc
two
antivcp
antibodi
figur
signal
antibodi
coloc
local
vcp
near
plasma
membran
observ
use
ntermin
direct
antibodi
rais
rabbit
sinc
ntermin
vcp
site
interact
sever
cofactor
hanzelmann
schindelin
hypothes
observ
absenc
coloc
dsrna
vcp
could
due
lack
ntermin
access
order
assess
effect
restrict
chikv
viral
isol
use
previou
experi
use
assess
role
vcp
infect
differ
chikv
isol
well
close
relat
onnv
distantli
relat
sfv
belong
sfv
clade
chikv
categor
three
main
genotyp
west
africa
eastcentralsouthafrican
ecsa
asian
genotyp
compar
chikungunya
strain
isol
la
reunion
epidem
la
reunion
isol
lr
indian
ind
strain
isol
india
epidem
patient
present
neurolog
complic
belong
ecsa
genotyp
also
compar
caribbean
crb
isol
belong
asian
genotyp
isol
outbreak
crb
island
decemb
previous
shown
less
pathogen
lr
isol
vitro
vivo
mous
model
teo
et
al
vcp
inhibit
show
dosedepend
inhibit
viral
gluc
product
virus
test
figur
dosedepend
decreas
zsgreen
signal
also
observ
cell
infect
zsgreentag
chikv
onnv
figur
addit
assess
effect
vcp
inhibit
chikv
replic
reproduc
relev
human
cell
relat
cell
type
infect
patient
human
foreskin
fibroblast
cell
line
bj
cell
muscl
cell
line
rd
cell
suhrbier
et
al
vcp
inhibit
result
dosedepend
inhibit
chikv
bj
rd
cell
figur
studi
show
sirna
target
vcp
figur
well
chemic
inhibitor
figur
abl
reduc
chikv
infect
replic
cell
timeofaddit
assay
use
specif
chemic
inhibitor
vcp
suggest
viru
life
cycl
step
involv
vcp
provir
factor
would
viral
rna
replic
rather
bind
entri
although
effect
vcp
inhibit
demonstr
conserv
across
differ
alphavirus
figur
variat
level
viru
inhibit
observ
differ
cell
type
viru
isol
variat
like
due
calcul
viru
cell
type
rel
luciferas
normal
signal
untreat
infect
intern
control
background
signal
come
initi
gluc
contain
inoculum
despit
provir
role
vcp
chikv
replic
observ
knockdown
chemic
inhibit
increas
viral
replic
upon
vcp
vcp
domain
overexpress
observ
supplementari
figur
consist
vcp
highli
abund
cytoplasm
protein
content
peter
et
al
zeiler
et
al
meyer
weihl
transfect
vcp
truncat
domain
mutant
show
inhibitori
effect
gluc
product
effect
surpris
truncat
vcp
known
dominantneg
mutant
vcp
ye
et
al
van
den
boom
et
al
result
consist
sirna
chemic
inhibitor
effect
interestingli
genomewid
screen
insect
cell
previous
identifi
vcp
provir
entri
factor
sinv
downregul
receptor
rose
et
al
panda
et
al
howev
observ
role
vcp
bind
factor
chikv
figur
b
consist
fact
chikv
alphavirus
bind
entri
independ
rose
et
al
observ
verifi
use
entri
assay
figur
show
effect
vcp
inhibit
intracellular
viral
level
consist
role
vcp
viral
rna
replic
therefor
exclud
role
viral
bind
entri
experiment
setup
howev
exclud
figur
vcp
local
chikv
replicas
compon
hek
cell
infect
moi
hpi
cell
plate
ibidi
microscopi
chamber
hour
postplat
cell
fix
permeabil
costain
duplic
vcp
indic
figur
cell
counterstain
dapi
confoc
acquisit
zstack
vcp
inhibit
prior
infect
could
also
result
lower
traffick
viral
receptor
entri
factor
nevertheless
transrepl
assay
confirm
role
vcp
inhibit
viral
rna
replic
independ
stabil
templat
avail
alphaviru
nsp
figur
addit
viral
replicas
compon
demonstr
coloc
partial
vcp
differenti
figur
differ
could
due
fact
signific
portion
anchor
plasma
membran
vcp
cytoplasm
result
consist
earlier
studi
sfv
hcv
show
associ
vcp
replic
complex
varjak
et
al
yi
et
al
role
vcp
viru
rna
replic
polioviru
enteroviru
human
cytomegaloviru
west
nile
viru
hcv
arita
et
al
wu
et
al
yi
et
al
lin
et
al
phongphaew
et
al
wang
et
al
yi
yuan
interestingli
vcp
also
involv
egress
viral
particl
polioviru
rift
valley
fever
viru
rvfv
arita
et
al
brahm
et
al
result
rvfv
particular
interest
studi
identifi
vcp
target
fdaapprov
drug
sorafenib
effect
rvfv
benedict
et
al
brahm
et
al
group
also
identifi
sorafenib
potenti
drug
reduc
replic
sever
alphavirus
includ
chikv
lundberg
et
al
would
interest
verifi
sorafenib
inhibit
alphavirus
vcpdepend
manner
similar
rvfv
interestingli
could
observ
coloc
vcp
dsrna
foci
replic
complex
figur
like
due
unavail
vcp
ntermin
recognit
antibodi
use
reinforc
lack
coloc
vcp
antibodi
recogn
cand
ntermini
figur
importantli
appar
reloc
vcp
avail
ctermin
infect
cell
membran
consist
local
dsrna
foci
studi
need
assess
vcp
involv
replic
complex
chikv
alphavirus
valosincontain
protein
essenti
host
protein
involv
wide
rang
cellular
process
meyer
weihl
link
one
describ
vcp
function
viral
replic
remain
poorli
understood
exampl
infect
viru
could
use
vcp
hijack
er
mitochondriaassoci
degrad
proteasom
up
modul
function
taylor
rutter
wolf
stolz
proteasom
activ
report
essenti
chikv
replic
karp
et
al
chikv
manipul
up
prevent
hostcel
imag
repres
three
independ
experi
acquir
brightfield
auto
exposur
fitc
fix
exposur
channel
c
rd
bj
cell
per
well
treat
increas
concentr
indic
figur
infect
pfu
chikvlrtag
gluc
viru
inoculum
remov
hpi
luminesc
supernat
assess
data
panel
b
repres
four
three
independ
experi
respect
present
mean
sd
analyz
mannwhitney
nonparametr
twotail
test
p
p
p
shutoff
fro
et
al
along
line
chikv
could
use
vcp
modul
function
autophagi
mechan
could
explain
chikv
induc
autophagi
papadopoulo
meyer
delay
cell
death
increas
replic
joubert
et
al
b
also
plausibl
vcp
role
membran
rearrang
zhang
wang
could
hijack
viru
order
form
invagin
membran
structur
replic
complex
effici
reid
et
al
would
explain
vcp
coloc
chikv
nsp
figur
presenc
replic
complex
hcv
sfv
varjak
et
al
yi
et
al
similarli
vcp
import
lipid
droplet
metabol
olzmann
et
al
site
chikv
also
shown
associ
remenyi
et
al
moreov
lipid
droplet
metabol
also
shown
import
flaviviru
replic
vcp
function
provir
host
factor
viru
replic
phongphaew
et
al
vcp
unfold
aggreg
protein
could
also
necessari
function
virus
exampl
hcv
infect
vcp
prevent
aggreg
nonfunct
yi
yuan
cellular
function
vcp
activ
schweitzer
et
al
stall
ribosom
turnov
verma
et
al
full
capac
autophagi
lysosom
system
papadopoulo
meyer
cellular
function
pathway
could
possess
proor
antivir
function
link
viru
interact
vcp
modul
function
could
also
present
avenu
futur
investig
conclud
shown
vcp
highli
conserv
connect
protein
function
multipl
cellular
process
provir
function
chikv
replic
effect
extend
sever
alphavirus
understand
exact
role
play
vcp
viru
replic
could
shed
light
highli
conserv
viral
subvers
mechan
cellular
machineri
via
multipurpos
protein
vcp
accumul
evid
suggest
understand
mechan
could
open
way
design
new
treatment
strategi
effect
wide
rang
virus
target
conserv
vcp
provir
role
human
embryon
kidney
cell
human
foreskin
fibroblast
bj
cell
human
muscl
rd
cell
african
green
monkey
kidney
vero
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
gibco
bj
cell
supplement
penicillinstreptomycin
gibco
cell
maintain
c
co
chikungunya
viru
infecti
clone
plasmid
contain
duplic
subgenom
promot
insert
gluc
gaussia
princep
luciferas
zsgreen
anthozoa
reef
coral
fluoresc
protein
nonstructur
structur
region
construct
isol
la
reunion
crb
region
ind
region
chikv
ind
strain
isol
bhk
cell
cerebr
spinal
fluid
ind
patient
epidem
gift
dr
ooi
eng
eong
dukenu
graduat
medic
school
singapor
subsequ
passag
vero
cell
infecti
clone
onnv
bessaud
et
al
ferguson
et
al
construct
similar
fashion
except
cmv
promot
place
upstream
viral
sequenc
duplic
subgenom
promot
report
gene
place
downstream
structur
region
chikv
onnv
produc
use
vitro
transcrib
viral
rna
noti
neb
linear
plasmid
use
mmessag
mmachin
ambion
viral
rna
transfect
vero
cell
use
lipofectamin
invitrogen
follow
manufactur
recommend
produc
transfect
plasmid
contain
infecti
cdna
cell
virus
passag
twice
vero
cell
obtain
suffici
titer
viru
stock
titrat
perform
standard
plaqu
assay
vero
cell
plate
format
chikv
transrepl
system
previous
publish
utt
et
al
utt
et
al
utt
et
al
modifi
insert
sequenc
encod
fluoresc
tdtomato
report
templat
use
human
rna
polymeras
promot
instead
promot
synthesi
noncap
rna
transfect
cell
abraham
et
al
briefli
substitut
promot
termin
templat
utt
et
al
human
rna
polymeras
promot
termin
abraham
et
al
sequenc
correspond
chikv
genom
place
start
site
promot
gluc
report
gene
substitut
sequenc
encod
tdtomato
use
restrictionbas
clone
obtain
construct
design
detail
descript
properti
system
publish
elsewher
utt
et
al
verif
templat
gener
plasmid
cell
plate
densiti
cell
per
well
plate
total
ng
plasmid
per
well
transfect
use
lipofectamin
invitrogen
follow
manufactur
recommend
full
transrepl
assay
cell
plate
densiti
cell
per
well
sixwel
plate
two
microgram
plasmid
plasmid
figur
per
well
cotransfect
use
lipofectamin
h
posttransfect
hpt
media
refresh
media
dmso
control
h
postmedia
refresh
cell
collect
rna
extract
use
nucleospin
rna
kit
machereynagel
follow
manufactur
protocol
cell
collect
half
lyze
ripa
buffer
immunoblot
half
process
flow
cytometri
predesign
dicer
substrat
sirna
vcp
purchas
idt
trifecta
kit
contain
nontarget
control
label
control
sirna
cell
plate
either
plate
plate
densiti
cellswel
sirna
transfect
nm
final
concentr
use
ratio
lipofectamin
pmol
dsirna
hpt
control
sirna
indic
transfect
effici
shown
h
post
sirna
transfect
cell
infect
overnight
glucor
zsgreentag
chikv
follow
rtqpcr
plaqu
assay
luciferas
assay
supernat
flow
cytometri
analysi
cell
respect
vcp
express
cell
lysat
verifi
western
blot
hpt
time
supernat
collect
dbeq
purchas
apexbio
technolog
llc
resuspend
dmso
final
concentr
mm
olx
selleckchem
resuspend
dmso
final
concentr
mm
cell
plate
cellswel
format
fibronectinco
plate
figur
adhes
glucexpress
virus
moi
pfu
moi
figur
serial
dilut
compound
ad
cell
figur
inoculum
remov
time
indic
legend
dilut
compound
ad
back
cell
h
incub
supernat
use
determin
luminesc
proxi
viral
replic
altern
zsgreenexpress
virus
use
moi
cell
plate
densiti
cell
per
well
plate
adhes
cell
infect
moi
volum
dmem
media
dmso
control
ice
c
co
h
altern
cell
infect
h
complet
complet
media
olx
inoculum
remov
cell
wash
pb
complet
media
contain
olx
olx
appli
cell
h
cell
wash
collect
pb
rna
extract
use
nucleospin
rna
kit
machereynagel
follow
manufactur
protocol
rel
quantit
elut
rna
quantifi
use
nanodrop
spectrophotomet
thermo
scientif
dilut
concentr
approxim
subject
qrtpcr
use
quantifast
sybr
green
rtpcr
kit
qiagen
accord
manufactur
protocol
qrtpcr
perform
appli
biosystem
abi
fast
realtim
pcr
system
plate
format
follow
condit
revers
transcript
step
c
min
cycl
b
pcr
initi
activ
step
c
min
cycl
c
cycl
c
follow
c
cycl
ct
c
valu
chikv
viral
rna
quantif
supernat
infect
cell
supernat
extract
use
qiamp
viral
rna
kit
qiagen
accord
manufactur
protocol
chikv
viral
genom
copi
quantifi
taqman
rtqpcr
target
viral
rna
neg
sens
region
previous
describ
kam
et
al
teo
et
al
carissimo
et
al
briefli
qrtpcr
perform
appli
biosystem
abi
fast
realtim
pcr
system
plate
format
follow
condit
revers
transcript
step
c
min
cycl
b
pcr
initi
activ
step
c
min
cycl
c
cycl
c
follow
c
min
cycl
viral
rna
copi
number
extrapol
use
sd
softwar
standard
curv
serial
dilut
chikv
rna
vitro
produc
transcript
rang
copi
per
primer
use
studi
given
tabl
luminesc
assess
use
glomax
multidetect
system
promega
integr
time
delay
inject
xenolight
rediject
coelenterazin
h
perkinelm
dilut
pb
gibco
mm
nacl
ambion
result
present
percentag
luminesc
treat
well
rel
luminesc
control
treat
well
cell
viabil
assay
carri
celltiterglo
luminesc
cell
viabil
assay
promega
serv
readout
cellular
atp
level
previous
describ
ching
et
al
briefli
serial
dilut
dbeq
ad
seed
fibronectinco
plate
h
incub
cell
viabil
assay
use
celltiterglo
reagent
promega
perform
per
manufactur
protocol
h
incub
room
temperatur
luminesc
emiss
detect
glomax
multidetect
system
promega
hek
cell
technic
replic
resuspend
cultur
media
pool
wash
pb
fix
min
bd
fac
lyse
solut
bd
bioscienc
acquir
lsr
fortessa
flow
cytomet
bd
bioscienc
fitc
pe
channel
flow
cytometri
analysi
perform
minimum
cell
per
replic
flowjo
flowjo
llc
singl
cell
assess
fitc
pe
posit
signal
data
express
infect
cell
treat
condit
rel
infect
cell
control
condit
mean
pe
intens
pe
posit
cell
treat
sampl
rel
mean
pe
intens
pe
posit
cell
control
sampl
fc
file
avail
supplementari
file
microscopi
imag
acquir
zoom
olympu
epifluoresc
microscop
fix
exposur
time
fitc
filter
auto
exposur
brightfield
filter
cellsen
dimens
softwar
olympu
tiff
imag
open
photoshop
adob
light
contrast
adjust
use
exact
paramet
pair
imag
convert
jpeg
format
inclus
figur
unmodifi
tiff
imag
avail
request
valosincontain
protein
vcp
domain
n
amplifi
pcr
cdna
use
primer
indic
tabl
hifi
polymeras
neb
follow
manufactur
recommend
pcr
ligat
tm
sigma
use
noti
hindiii
restrict
digest
neb
gener
flagtag
vcp
full
length
express
plasmid
fl
mutant
n
domain
gener
use
sitedirect
mutagenesi
sdm
kit
neb
follow
manufactur
recommend
primer
given
tabl
plasmid
verifi
sanger
sequenc
use
correct
express
confirm
western
blot
use
monoclon
mous
antiflag
sigma
ref
shown
cell
dislodg
plate
pb
pellet
centrifug
min
g
lyse
ripa
buffer
invitrogen
sampl
mix
vv
laemmli
buffer
biorad
sigma
heat
min
c
sampl
migrat
tgx
miniprotean
gel
biorad
transfer
nitrocellulos
membran
biorad
use
semidri
system
bjerrum
schafernielsen
buffer
mm
ultrapur
tri
invitrogen
mm
glycin
biorad
vv
emsur
methanol
emd
millipor
membran
block
wtv
nonfat
milk
powder
nacalai
tesqu
tri
buffer
salin
base
tween
vv
sigma
h
stain
antibodi
use
stain
mous
monoclon
antihuman
vcp
clone
biolegend
mous
monoclon
antihuman
gapdh
clone
biolegend
antichikv
affin
purifi
igg
produc
rabbit
inhous
goat
antimous
goat
antirabbit
antibodi
coupl
hrp
purchas
santa
cruz
biotechnolog
protein
reveal
use
westernbright
ecl
hrp
substrat
advansta
signal
acquir
chemidoc
screen
touch
model
biorad
nonsatur
imag
quantifi
use
imagelab
softwar
biorad
raw
imag
western
blot
avail
request
cell
infect
plate
h
wash
trypsin
replat
complet
media
ibidi
plate
coat
fibronectin
h
postrepl
cell
wash
twice
pb
fix
paraformaldehydepb
solut
min
slide
wash
three
time
pb
incub
min
permabil
block
buffer
pb
tween
triton
bsa
fb
cell
incub
h
room
temperatur
mous
antivcp
dilut
santa
cruz
biotechnolog
monoclon
ctermin
rabbit
antivcp
dilut
thermofish
mous
monoclon
antidsrna
dilut
scicon
rabbit
inhous
dilut
slide
wash
four
time
pb
tween
incub
h
antirabbit
antimous
thermofish
dilut
slide
wash
four
time
pb
tween
wash
three
time
pb
prolong
gold
antifad
reagent
dapi
molecular
probe
ad
well
imag
acquir
olympu
microscop
equip
confoc
system
use
version
imag
analyz
imari
version
bitplan
pearson
correl
coeffici
coloc
channel
use
automat
threshold
function
confoc
imag
present
figur
export
tiff
file
use
softwar
incorpor
figur
without
modif
statist
analys
perform
use
graphpad
prism
version
maco
graphpad
softwar
use
statist
test
mention
figur
legend
pvalu
consid
statist
signific
repres
p
p
p
dataset
gener
studi
avail
request
correspond
author
gc
conceiv
design
experi
analyz
data
gc
yhc
au
fa
tkc
perform
experi
gc
ln
wrote
manuscript
au
contribut
reagent
materi
author
review
approv
final
manuscript
work
fund
agenc
scienc
technolog
research
star
core
grant
yhc
fa
support
star
graduat
scholarship
ag
flow
cytometri
platform
part
sign
immunomonitor
platform
support
grant
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
thank
prof
ooi
eng
eong
provid
passag
one
ind
isol
use
studi
would
also
like
thank
dr
kaier
eng
teckhui
teo
fokmoon
lum
critic
read
manuscript
supplementari
materi
articl
found
onlin
http
supplementarymateri
figur
viral
rna
quantif
plaqu
assay
luciferas
luminesc
show
similar
result
hundr
thousand
hek
cell
per
well
transfect
sirna
nm
h
cell
infect
pfu
gluctag
chikvlr
hpi
supernat
collect
well
viral
rna
rtqpcr
plaqu
assay
luminesc
read
b
spearman
correl
differ
read
result
present
panel
result
two
independ
experi
well
per
condit
experi
schemat
represent
flagtag
vcp
vcp
domain
construct
b
plate
format
cell
per
well
day
postplat
cell
transfect
ng
per
well
indic
vcp
construct
empti
plasmid
control
day
posttransfect
cell
infect
use
pfu
per
well
gluctag
chikv
incub
h
time
supernat
collect
luciferas
assay
data
panel
b
repres
four
independ
experi
present
mean
sd
analyz
mannwhitney
nonparametr
twotail
test
p
file
flow
cytometri
fc
file
gener
figur
frontier
microbiolog
wwwfrontiersinorg
